← Open Payments lookup

CASEY TILLERY: Open Payments

NPI 1710227905 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$913 in 39 payments from 11 companies in 2025. Trend: 2023 $189 · 2024 $464 · 2025 $913

Food & beverage: $913
CompanyPaymentsAmount
GlaxoSmithKline, LLC.13$323
AstraZeneca Pharmaceuticals LP3$138
Boehringer Ingelheim Pharmaceuticals, Inc.5$102
Verona Pharma, Inc.4$86
Viatris Specialty LLC4$72
GENZYME CORPORATION3$63
Regeneron Healthcare Solutions, Inc.2$42
Philips North America LLC2$31
United Therapeutics Corporation1$24
Insmed, Inc.1$17

Products named: NUCALA, AIRSUPRA, DUPIXENT, Ohtuvayre, YUPELRI, JASCAYD, TRELEGY ELLIPTA, OFEV.

Industry payments across MS — which companies pay providers there.